Your search history is turned on.
Date: April 29, 2024 Jurisdictions: Alberta, Ontario
Create participation fee form FORM 13-502F1 CLASS 1 AND CLASS 3B REPORTING ISSUERS PARTICIPATION FEE MANAGEMENT CERTIFICATION I, LIM, Toby, an officer of the reporting issuer noted below have examined this Form 13-502F1 (the Form) being submitted hereunder to the Ontario Securities Commission and certify that to my knowledge, having exercised reasonable dil...
Date: April 29, 2024 Jurisdictions: Alberta, British Columbia, Ontario
_ 1 Form 52-109FV1 Certification of Annual Filings Venture Issuer Basic Certificate I, Michael Iverson, Independent Director Signing in Place of CFO of NanoSphere Health Sciences Inc., certify the following: 1. Review: I have reviewed the AIF, if any, annual financial statements and annual MD&A, including, for greater certainty,...
NanoSphere Health Sciences Inc. Managements Discussion & Analysis For the year ended December 31, 2023 NANOSPHERE HEALTH SCIENCES INC. Form 51-102F1 Managements Discussion and Analysis For the Year Ended December 31, 2023 2 The following Manage...
Create participation fee form Note: [01 Mar 2017] The following is a consolidation of 13-501F1. It incorporates amendments to this document that came into effect on March 1, 2017. This consolidation is provided for your convenience and should not be relied on as authoritative. FORM 13-501F1 CLASS 1 REPORTING ISSUERS AND CLASS 3B REPORTING ISSUERS PARTICIPATI...
_ 1 Form 52-109FV1 Certification of Annual Filings Venture Issuer Basic Certificate I, Toby Lim, Independent Director Signing in Place of CEO of NanoSphere Health Sciences Inc., certify the following: 1. Review: I have reviewed the AIF, if any, annual financial statements and annual MD&A, including, for greater certainty, all do...
Microsoft Word - NSHS 2023 YE FS final.docx CONSOLIDATED FINANCIAL STATEMENTS (Expressed in United States Dollars) FOR THE YEARS ENDED DECEMBER 31, 2023 AND 2022 INDEPENDENT AUDITORS REPORT To the Shareholders of Nanosphere Health Sciences I...
Date: November 29, 2023 Jurisdictions: Alberta, British Columbia, Ontario
_ 1 Form 52-109FV2 Certification of Interim Filings Venture Issuer Basic Certificate I, Michael Iverson, Independent Director Signing in Place of CFO of NanoSphere Health Sciences Inc., certify the following: 1. Review: I have reviewed the interim financial report and interim MD&A (together, the interim filings) of NanoSphere H...
_ 1 Form 52-109FV2 Certification of Interim Filings Venture Issuer Basic Certificate I, Toby Lim, Independent Director Signing in Place of CEO of NanoSphere Health Sciences Inc., certify the following: 1. Review: I have reviewed the interim financial report and interim MD&A (together, the interim filings) of NanoSphere Health S...
1 CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS (Expressed in United States Dollars) (Unaudited) FOR THE NINE MONTHS ENDED SEPTEMBER 30, 2023 AND 2022 2 NOTICE TO READER Under National Instrument 51-102, Part 4,...
NanoSphere Health Sciences Inc. Managements Discussion & Analysis For the nine months ended September 30, 2023 NANOSPHERE HEALTH SCIENCES INC. Form 51-102F1 Managements Discussion and Analysis For the Period Ended September 30, 2023 2 The follo...